Clinical Trials Directory

Trials / Completed

CompletedNCT03771274

Tecnis ZLB00 & Symfony Intraocular Lens Combination Outcomes

Visual Outcomes of an Extended Depth of Focus (EDOF) Intraocular Lens (IOL) Combined With a Multifocal (MF) IOL

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
Carolina Eyecare Physicians, LLC · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Current visual outcomes expectations of cataract patients are similar to those of refractive surgery patients. Their desire is to be spectacle independent for far, intermediate and near vision activities. Some may have already enjoyed freedom from glasses and would like to continue after the cataracts are removed. Different options are available. These options include: mono-vision and presbyopia correcting intraocular lenses (IOL). Presbyopia correcting IOLs include accommodative, multifocals and extended depth of focus (EDOF) IOLs. In a previous study, the visual outcomes of the EDOF Toric IOL were evaluated when both eyes were targeted for plano and when the non-dominant eye was set for a small residual myopic error (-0.50 D) or nanovision in patients with astigmatism. The nanovision approach, appeared to provide similar binocular acuity at distance and intermediate but better acuity at near. The purpose of this study is to evaluate the visual outcomes of an EDOF IOL when combined with a multifocal IOL with a +3.25 D add in patients with or without astigmatism undergoing routine cataract surgery.

Conditions

Interventions

TypeNameDescription
DEVICETecnis ZLB00 & Symfony IOLThe Symfony IOL will be implanted in the dominant eye while the Tecnis ZLB00 will be implanted in the non-dominant eye.

Timeline

Start date
2018-12-07
Primary completion
2019-10-31
Completion
2019-10-31
First posted
2018-12-11
Last updated
2020-08-10
Results posted
2020-08-10

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03771274. Inclusion in this directory is not an endorsement.